CDC panel recommends full FDA approval for Moderna COVID-19 vaccine

Published



A key advisory panel for the Centers for Disease Control and Prevention voted to give full approval to Moderna’s COVID-19 vaccine more than a year after it was granted an emergency use authorization.

The CDC’s Advisory Committee on Immunization Practices voted 13-0 to recommend full approval for Moderna’s two-dose vaccine series for ages 18 years and older, marketed as Spikevax, after receiving full approval from the Food and Drug Administration earlier this week, according to CNN.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.